Item Financial Statements From 2010 to 2024
| INLB Stock | USD 0.0001 0.00 0.00% |
Check Item 9 financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Item 9's main balance sheet or income statement drivers, such as , as well as many indicators such as . Item financial statements analysis is a perfect complement when working with Item 9 Valuation or Volatility modules.
Item |
Item 9 Labs Company Profit Margin Analysis
Item 9's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Item 9 Profit Margin | (1.43) % |
Most of Item 9's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Item 9 Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Item 9 Labs has a Profit Margin of -1.4314%. This is 87.23% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The profit margin for all United States stocks is 12.71% higher than that of the company.
Item 9 Labs Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Item 9's current stock value. Our valuation model uses many indicators to compare Item 9 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Item 9 competition to find correlations between indicators driving Item 9's intrinsic value. More Info.Item 9 Labs is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Item 9 by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Item 9's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Item 9 Financial Statements
Item 9 stakeholders use historical fundamental indicators, such as Item 9's revenue or net income, to determine how well the company is positioned to perform in the future. Although Item 9 investors may analyze each financial statement separately, they are all interrelated. For example, changes in Item 9's assets and liabilities are reflected in the revenues and expenses on Item 9's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Item 9 Labs. Please read more on our technical analysis and fundamental analysis pages.
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 103 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Item Pink Sheet
Item 9 financial ratios help investors to determine whether Item Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Item with respect to the benefits of owning Item 9 security.